gimli
CONCORD stock AI analysis

CONCORD Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers

CONCORD DRUGS LIMITED is a stock in Unclassified. This Gimli page shows the latest available CONCORD price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.

Price
₹n/a
1W return
n/a
1M return
n/a
3M return
n/a
6M return
n/a
1Y return
n/a
Market cap
₹n/a
PE
n/a
PB
n/a
ROE
n/a
ROCE
n/a
RSI
n/a
Turnover
₹n/a

Why it can matter in screens

Quick Answers

What is the latest CONCORD stock price?

The latest stored price for CONCORD is Rs n/a as of the latest available market snapshot.

Is CONCORD above its 50DMA and 200DMA?

CONCORD is 50DMA unavailable, 200DMA unavailable. The latest 50DMA is n/a and the latest 200DMA is n/a.

What are CONCORD PE, ROE and ROCE?

CONCORD has PE n/a, ROE n/a, and ROCE n/a in Gimli's latest available snapshot.

How has CONCORD performed recently?

CONCORD has returned n/a over 1 month, n/a over 3 months, and n/a over 12 months in the latest stored data.

Is this stock page investment advice?

No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.

Financials and Ownership

Quarterly income statement

No recent data available.

Annual income statement

No recent data available.

Balance sheet

No recent data available.

Cash flow

No recent data available.

Shareholding Trend

No recent data available.

Industry Peers

No recent data available.

Try these prompts

Related screen ideas

Data snapshot: latest available. Not investment advice.